| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/09/2005 | EP1505076A2 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504266A2 Method for simultaneously detecting an antigen and an antibody of an infectious microorganism |
| 02/09/2005 | EP1504102A2 Chimeric ige polypeptides and host cells |
| 02/09/2005 | EP1504036A2 Toxin-related antibodies with antimicrobial and antiviral activity |
| 02/09/2005 | EP1504035A2 Antibodies specific for human cd22 and their therapeutic and diagnostic uses |
| 02/09/2005 | EP1504034A1 Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1504017A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 02/09/2005 | EP1503801A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/09/2005 | EP1503799A2 Immunogenic, monoclonal antibody |
| 02/09/2005 | EP1503795A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 02/09/2005 | EP1503794A1 Methods of treatement using ctla-4 antibodies |
| 02/09/2005 | EP1503787A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 02/09/2005 | EP1503785A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 02/09/2005 | EP1503781A1 Treatment for weight loss |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1456223A4 Rapidly maturing fluorescent proteins and methods for using the same |
| 02/09/2005 | EP1155323B1 Detection method for microthrix parvicella |
| 02/09/2005 | EP1078099A4 Identifying peptide ligands of target proteins with target complementary library technology (tclt) |
| 02/09/2005 | EP1056860B1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 02/09/2005 | EP1051427A4 Spoil protein and nucleic acid molecules and uses therefor |
| 02/09/2005 | EP1030923B1 Method for producing virus-like particles on the basis of polyoma viruses |
| 02/09/2005 | EP1017805B1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 02/09/2005 | EP0843818B1 Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents |
| 02/09/2005 | EP0700438B1 Opioid receptors: compositions and methods |
| 02/09/2005 | EP0383799B2 Adheson variants |
| 02/09/2005 | CN1578673A Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders |
| 02/09/2005 | CN1576840A Methods for diagnosis and therapy of cancer and composition useful therein |
| 02/09/2005 | CN1576369A Prawn leukasmus rhabdovirus dUTPase gene and coded polypeptide thereof |
| 02/09/2005 | CN1576368A Prawn leukasmus rhabdovirus VP26 gene correlated with infection and coded polypeptide thereof |
| 02/09/2005 | CN1576367A Prawn leukasmus rhabdovirus WP486 gene and coded polypeptide thereof |
| 02/09/2005 | CN1576281A Viral clearance process |
| 02/09/2005 | CN1188528C Intercellular adhesion molecule-3 and its binding ligands |
| 02/09/2005 | CN1188426C Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 02/09/2005 | CN1188169C Use of antibodies for anticancer vaccination |
| 02/08/2005 | US6853215 Programmable I/O element circuit for high speed logic devices |
| 02/08/2005 | US6852839 Fhm, a novel member of the TNF ligand supergene family |
| 02/08/2005 | US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
| 02/08/2005 | US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 02/08/2005 | US6852703 A vector comprising a nucleotide sequence of interest ("NOI") encoding a product of interest ("POI") is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI |
| 02/08/2005 | US6852520 DSP-2 dual-specificity phosphatase |
| 02/08/2005 | US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6 |
| 02/08/2005 | US6852510 Host cells containing multiple integrating vectors |
| 02/08/2005 | US6852509 Anti-P53 single-chain antibody fragments and their uses |
| 02/08/2005 | US6852507 Recombinant baculovirus and use thereof in the production of monoclonal antibodies |
| 02/08/2005 | US6852497 Fusion protein |
| 02/08/2005 | US6852482 For drug screening; Alzheimer's disease prophylaxis/therapy |
| 02/08/2005 | US6852352 Soluble milk protein concentrate devoid of chemical precipitants: alpha-lactalbumin-enriched, beta-lactoglobulin and alpha-lactalbumin-enriched whey protein isolate (WPI), or sialyllactose-enriched WPI |
| 02/08/2005 | US6852320 T cell inhibitory receptor compositions and uses thereof |
| 02/08/2005 | US6852319 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin |
| 02/08/2005 | US6852318 Comprises contacting tissue with integrin |
| 02/08/2005 | US6852313 For treating blood disorders; cytokines/interleukins |
| 02/08/2005 | CA2270227C Detection of antigens via oligonucleotide antibody conjugates |
| 02/08/2005 | CA2180103C Gene encoding adseverin |
| 02/08/2005 | CA2110933C Kainate-binding, human cns receptors of the eaa3 family |
| 02/05/2005 | CA2473337A1 Polymorphisms of the 5' region of the human 5-ht1a gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 02/03/2005 | WO2005010485A2 Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials |
| 02/03/2005 | WO2005010205A2 Biomarkers fo aggrecanase activity |
| 02/03/2005 | WO2005010167A2 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 02/03/2005 | WO2005010153A2 Antibodies and uses thereof |
| 02/03/2005 | WO2005010151A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/03/2005 | WO2005010049A2 Tgf-beta1 ligands |
| 02/03/2005 | WO2005010048A2 Rg1 antibodies and uses thereof |
| 02/03/2005 | WO2005010044A2 Il-17 a/f heterologous polypeptides and therapeutic uses thereof |
| 02/03/2005 | WO2005010036A1 Vaccine and compositions for the prevention and treatment of neisserial infections |
| 02/03/2005 | WO2005010034A1 Soluble fragments of the sars-cov spike glycoprotein |
| 02/03/2005 | WO2005010032A2 Replikin peptides and uses thereof |
| 02/03/2005 | WO2005010023A2 Method for prediction of an epitope |
| 02/03/2005 | WO2005009465A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 02/03/2005 | WO2005009464A1 Administration of anti-cytokine f(ab')2 antibody fragments |
| 02/03/2005 | WO2005009396A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections |
| 02/03/2005 | WO2005009369A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2004112835A3 Suppression of transplant rejection |
| 02/03/2005 | WO2004106366A8 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 02/03/2005 | WO2004097041A3 Screening method for binding molecules |
| 02/03/2005 | WO2004083250A9 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme |
| 02/03/2005 | WO2004081190A3 Uses of il-23 agonists and antagonists; related reagents |
| 02/03/2005 | WO2004052277A3 Anthrax antitoxins |
| 02/03/2005 | WO2004050849A3 Recombinant immunotoxin and use in treating tumors |
| 02/03/2005 | WO2004029214A3 Lfa-1 alpha subunit antibodies and methods of use |
| 02/03/2005 | WO2004006860A3 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 02/03/2005 | WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof |
| 02/03/2005 | WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr |
| 02/03/2005 | WO2003064606A3 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 02/03/2005 | WO2003059257A8 Anti-angiogenic proteins and fragmentsand methods of use thereof |
| 02/03/2005 | WO2003015691A3 RAPID IMPROVEMENT OF COGNITION IN CONDITIONS RELATED TO A$g(b) |
| 02/03/2005 | WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| 02/03/2005 | WO2002099119A3 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 02/03/2005 | WO2002092837A3 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy |
| 02/03/2005 | US20050028230 Expresion vector comprising nucleotide sequences coding membrane glycoprotein for use in generation of transgenic animal models for identifying modulators which reduce concentration of preferential biological agents in tissues of cells |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders |
| 02/03/2005 | US20050027106 Monoclonal antibodies for use in diagnosis, prevention, classification and treatment of cell proliferative disorders |
| 02/03/2005 | US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |